Ligand‐independent EphA2 contributes to chemoresistance in small‐cell lung cancer by enhancing PRMT1‐mediated SOX2 methylation

Chemoresistance is the crux of clinical treatment failure of small‐cell lung cancer (SCLC). Cancer stem cells play a critical role in therapeutic resistance of malignant tumors. Studies have shown that the role of erythropoietin‐producing hepatocellular A2 (EphA2) in tumors is complex. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shumei, Wang, Qiuping, Wen, Yang, Wang, Yu, Li, Man, Wang, Qiongyao, Peng, Juan, Guo, Linlang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986087/
https://www.ncbi.nlm.nih.gov/pubmed/36377249
http://dx.doi.org/10.1111/cas.15653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986087/
https://www.ncbi.nlm.nih.gov/pubmed/36377249
http://dx.doi.org/10.1111/cas.15653

Ejemplares similares